TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/5/24 21:30 | 3/1/24 | ABSI | Absci Corp | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P | 1,000 | 4.50 | 0 | 222 | 3 | 8,253 | I | |||||||||||||||
12/28/23 21:30 | 12/26/23 | FATE | Fate Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | 1 | 3 | P.dm | 2,026 | 5.84 | 0 | 347 | 3 | 13,180 | I | |||||||||||||||
11/22/23 16:15 | 11/20/23 | AUGX | Augmedix, Inc. | DE | BizSv | BizSv | Business Services | 1 | 2 | P.ad | 12,500 | 4.00 | 0 | 3,125 | 14 | 25,850 | M | ||||||||||||||
7/3/23 21:45 | 6/29/23 | IGMS | Igm Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 1 | P | 758 | 9.42 | 0 | 80 | 1 | 5,949 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |